Panelists discuss the role of molecular testing in metastatic non–-small cell lung cancer (NSCLC), emphasizing its importance in identifying actionable mutations and guiding personalized treatment ...

Panelists discuss decision-making in metastatic non–-small cell lung cancer (NSCLC) when molecular testing results are delayed, focusing on strategies to optimize treatment while awaiting results.

Konica Minolta Healthcare Americas, Inc., is pleased to announce the publication of a case study by clinicians in the pulmonary and radiology departments at ASST Fatebenefratelli Sacco (Milan, Italy) ...